Endoscopic ultrasound sits in a category most equipment financing programs handle poorly. The instrument straddles two disciplines (gastroenterology and diagnostic imaging), the unit cost is high, and the procedural value is significant enough that a GI group or academic medical program depends on it for a substantial portion of its procedural revenue. When the system is down or unavailable, patients wait, procedures get deferred, and the revenue gap shows up quickly. We understand the EUS program and finance it with the urgency and credit flexibility that the investment justifies.
EUS systems are used to evaluate subepithelial masses, stage pancreatic and upper GI malignancies, sample lymph nodes and solid organs via EUS-guided fine needle aspiration (EUS-FNA) or biopsy (EUS-FNB), drain pancreatic pseudocysts, and perform a growing range of therapeutic interventions including choledochoduodenostomy and gastroenterostomy. The platforms that support all of these applications are premium instruments. Full EUS systems with a radial echoendoscope, a linear (therapeutic) echoendoscope, a dedicated ultrasound processor, and procedure accessories run $150,000 to $400,000+ depending on manufacturer and configuration. That's the transaction range where our financing program is most useful.